4.6 Article

The Internally Truncated LRP5 Receptor Presents a Therapeutic Target in Breast Cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer

H. Suzuki et al.

BRITISH JOURNAL OF CANCER (2008)

Article Oncology

Rad6B is a positive regulator of β-catenin stabilization

Malathy P. V. Shekhar et al.

CANCER RESEARCH (2008)

Article Oncology

WNT signaling pathway and stem cell signaling network

Masuko Katoh et al.

CLINICAL CANCER RESEARCH (2007)

Review Biochemistry & Molecular Biology

Novel antibodies as anticancer agents

I. Zafir-Lavie et al.

ONCOGENE (2007)

Review Biochemistry & Molecular Biology

Current role of antibody therapy in patients with metastatic colorectal cancer

P. Pfeiffer et al.

ONCOGENE (2007)

Article Cell Biology

Wnt/β-catenin signaling in cancer stemness and malignant behavior

Riccardo Fodde et al.

CURRENT OPINION IN CELL BIOLOGY (2007)

Review Cell Biology

The many ways of Wnt in cancer

Paul Polakis

CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)

Review Cell Biology

Wnt signalingg stem cells and the cellular origin of breast cancer

Charlotta Lindvall et al.

STEM CELL REVIEWS (2007)

Article Anatomy & Morphology

beta-catenin/LEF-1 signalling in breast cancer - Central players activated by a plethora of inputs

Christoph A. Gebeshuber et al.

CELLS TISSUES ORGANS (2007)

Review Biotechnology & Applied Microbiology

Mining the Wnt pathway for cancer therapeutics

Nick Barker et al.

NATURE REVIEWS DRUG DISCOVERY (2006)

Article Biochemistry & Molecular Biology

The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis

Charlotta Lindvall et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Review Biochemistry & Molecular Biology

Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors

Michael D. Gordon et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Review Cell Biology

Wnt signaling pathway in mammary gland development and carcinogenesis

Gulisa Turashvili et al.

PATHOBIOLOGY (2006)

Article Oncology

Wnt proteins in mammary development and cancer

KR Brennan et al.

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2004)

Article Biochemistry & Molecular Biology

DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway

A Niida et al.

ONCOGENE (2004)

Article Biochemistry & Molecular Biology

The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with mesd

YH Zhang et al.

MOLECULAR AND CELLULAR BIOLOGY (2004)

Article Multidisciplinary Sciences

Prospective identification of tumorigenic breast cancer cells

M Al-Hajj et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Biochemistry & Molecular Biology

Wnt signaling controls the phosphorylation status of β-catenin

M van Noort et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Biochemistry & Molecular Biology

Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6

MV Semënov et al.

CURRENT BIOLOGY (2001)

Article Multidisciplinary Sciences

LDL-receptor-related protein 6 is a receptor for Dickkopf proteins

BY Mao et al.

NATURE (2001)

Article Multidisciplinary Sciences

β-catenin, a novel prognostic marker for breast cancer:: Its roles in cyclin D1 expression and cancer progression

SY Lin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)